LUN and HLUN-B Related Headlines
Go Back- Tarek Samad appointed EVP, Head of Research & Development at Lundbeck
- Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026
- Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting
- Lundbeck appoints Markus Kede SVP & Chief AI Officer
- Lundbeck appoints Chief AI Officer
- Lundbeck presents new real-world data highlighting meaningful improvements in patients severely impacted by migraine initiating Vyepti® (eptinezumab), at HCOP Annual Conference
LUN and HLUN-B Related Press Releases
Go Back- Tarek Samad appointed EVP, Head of Research & Development at Lundbeck
- Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026
- Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting
- Lundbeck appoints Chief AI Officer
- Lundbeck presents new real-world data highlighting meaningful improvements in patients severely impacted by migraine initiating Vyepti® (eptinezumab), at HCOP Annual Conference
